Skip to main content
Log in

Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability. Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and prognostic significance of patients with gastric cancer. The expression patterns of the NUAK1 protein in 117 primary archival gastric cancer specimens and 46 adjacent normal epithelial tissues from patients were detected by immunohistochemistry assay. Staining evaluation results were analyzed statistically in relation to various clinicopathological characters, recurrence-free survival and overall survival. High level of NUAK1 expression was detected in gastric cancer, significantly more than in adjacent normal epithelial cells. In gastric cancer, NUAK1 was positively correlated with depth of invasion, lymph node metastasis, pathological stage, surgical resection and histological differentiation. However, no correlations between NUAK1 expression and patients’ age, sex, tumor size, location, CA19-9 or CEA were detected. The recurrence-free survival and overall survival were significantly shorter for patients with NUAK1 higher scores than those with NUAK1 lower scores. Multivariate analysis identified NUAK1 was an independent prognostic factor for both recurrence-free survival and overall survival. Our findings provided convincing evidence for NUAK1 overexpression, which was tightly associated with more aggressive tumor behavior and a poor prognosis, indicating that NUAK1 is a valuable molecular biomarker for gastric cancer progression. It might also act as a promising target for both prognostic prediction and therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765–81. doi:10.1016/j.ejca.2009.12.014.

    Article  CAS  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.

    Article  PubMed  Google Scholar 

  3. Bernal C, Aguayo F, Villarroel C, Vargas M, Diaz I, Ossandon FJ, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res. 2008;14(19):6264–9. doi:10.1158/1078-0432.CCR-07-4522.

    Article  CAS  PubMed  Google Scholar 

  4. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57(1):55–62.

    Article  CAS  PubMed  Google Scholar 

  5. Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Miyamoto S, Ogura T, et al. Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene. 2004;23(42):7067–75. doi:10.1038/sj.onc.1207963.

    Article  CAS  PubMed  Google Scholar 

  6. Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, et al. ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol. 2004;164(3):987–95.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Chen P, Li K, Liang Y, Li L, Zhu X. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion. Exp Lung Res. 2013;39(1):9–17. doi:10.3109/01902148.2012.744115.

    Article  CAS  PubMed  Google Scholar 

  8. Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z, et al. ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome. Eur J Cancer. 2013;49(3):752–63. doi:10.1016/j.ejca.2012.09.018.

    Article  CAS  PubMed  Google Scholar 

  9. Kinoshita R, Iwadate M, Umeyama H, Taguchi YH. Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets. BMC Syst Biol. 2014;8(Suppl 1):S4. doi:10.1186/1752-0509-8-S1-S4.

    Article  PubMed  Google Scholar 

  10. Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, et al. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma. Tumour Biol. 2013;34(3):1913–8. doi:10.1007/s13277-013-0735-x.

    Article  CAS  PubMed  Google Scholar 

  11. Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, et al. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol. 2013;30(2):595. doi:10.1007/s12032-013-0595-7.

    Article  PubMed  Google Scholar 

  12. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer. 2008;123(8):1787–96. doi:10.1002/ijc.23746.

    Article  CAS  PubMed  Google Scholar 

  13. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17–20.

    PubMed  Google Scholar 

  14. Hardie DG, Alessi DR. LKB1 and AMPK and the cancer-metabolism link: ten years after. BMC Biol. 2013;11:36. doi:10.1186/1741-7007-11-36.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Sun X, Gao L, Chien HY, Li WC, Zhao J. The regulation and function of the NUAK family. J Mol Endocrinol. 2013;51(2):R15–22. doi:10.1530/JME-13-0063.

    Article  CAS  PubMed  Google Scholar 

  16. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, et al. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem. 2003;278(1):48–53. doi:10.1074/jbc.M206025200.

    Article  CAS  PubMed  Google Scholar 

  17. Koh HJ, Toyoda T, Fujii N, Jung MM, Rathod A, Middelbeek RJ, et al. Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc Natl Acad Sci USA. 2010;107(35):15541–6. doi:10.1073/pnas.1008131107.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hou X, Liu JE, Liu W, Liu CY, Liu ZY, Sun ZY. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation. Oncogene. 2011;30(26):2933–42. doi:10.1038/onc.2011.19.

    Article  CAS  PubMed  Google Scholar 

  19. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol. 2004;24(8):3526–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J. 2010;29(2):376–86. doi:10.1038/emboj.2009.342.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Liu L, Ulbrich J, Muller J, Wustefeld T, Aeberhard L, Kress TR, et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature. 2012;483(7391):608–12. doi:10.1038/nature10927.

    Article  CAS  PubMed  Google Scholar 

  22. Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer. 2000;3(4):177–86.

    Article  PubMed  Google Scholar 

  23. Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W, et al. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer. 2011;129(4):887–95. doi:10.1002/ijc.25734.

    Article  CAS  PubMed  Google Scholar 

  24. Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29(3):1716–22. doi:10.1007/s12032-011-9990-0.

    Article  CAS  PubMed  Google Scholar 

  25. Chen W, Wang J, Li X, Li J, Zhou L, Qiu T, et al. Prognostic significance of BRCA1 expression in gastric cancer. Med Oncol. 2013;30(1):423. doi:10.1007/s12032-012-0423-5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by Key Programs of Educational Commission of Anhui Province (No. KJ2010A181) and Medical Scientific Research Foundation of Anhui Province, China (No. 09A034).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jia-cong Chang.

Additional information

Xiao-tian Ye and Ai-jun Guo have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, Xt., Guo, Aj., Yin, Pf. et al. Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer. Med Oncol 31, 61 (2014). https://doi.org/10.1007/s12032-014-0061-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0061-1

Keywords

Navigation